SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-172070
Filing Date
2014-04-30
Accepted
2014-04-30 16:11:40
Documents
6
Period of Report
2014-06-25
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d716112ddef14a.htm DEF 14A 940206
2 GRAPHIC g716112g36i66.jpg GRAPHIC 6692
3 GRAPHIC g716112g45r25.jpg GRAPHIC 31766
4 GRAPHIC g716112g78h81.jpg GRAPHIC 45857
5 GRAPHIC g716112pc_001.jpg GRAPHIC 139536
6 GRAPHIC g716112pc_002.jpg GRAPHIC 122955
  Complete submission text file 0001193125-14-172070.txt   1420017
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 14798834
SIC: 2834 Pharmaceutical Preparations